Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Immunovia AB ( (SE:IMMNOV) ) has provided an announcement.
Immunovia AB has announced an Extraordinary General Meeting (EGM) scheduled for January 22, 2026, with key resolutions including a proposed reverse share split in a 1:100 ratio and amendments to the Articles of Association to facilitate this change. The reverse share split aims to optimize the number of company shares, which could have significant implications for shareholder value and operational efficiency.
More about Immunovia AB
Immunovia AB is a biotechnology company operating in the healthcare and diagnostics industry, specializing in innovative solutions for early detection of complex diseases, particularly utilizing advanced diagnostic technologies.
Average Trading Volume: 6,356,626
Technical Sentiment Signal: Sell
Current Market Cap: SEK165.8M
For detailed information about IMMNOV stock, go to TipRanks’ Stock Analysis page.